Profile | GDS4284 / 216755_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 499.734 | 64 |
GSM687648 | Patient 402 control | 930.784 | 73 |
GSM687653 | Patient 403 control | 1162.06 | 76 |
GSM687658 | Patient 404 control | 1538.18 | 80 |
GSM687663 | Patient 411 control | 2545.48 | 87 |
GSM687668 | Patient 422 control | 1607.46 | 81 |
GSM687673 | Patient 424 control | 2407.95 | 86 |
GSM687678 | Patient 425 control | 1004.13 | 73 |
GSM687683 | Patient 427 control | 1974.57 | 84 |
GSM687688 | Patient 428 control | 1113.94 | 76 |
GSM687695 | Patient 441 control | 777.44 | 71 |
GSM687699 | Patient 443 control | 1493.37 | 80 |
GSM687704 | Patient 444 control | 3970.41 | 91 |
GSM687707 | Patient 448 control | 1855.23 | 83 |
GSM687712 | Patient 449 control | 940.745 | 73 |
GSM687719 | Patient 450 control | 1611.67 | 81 |
GSM687724 | Patient 451 control | 3108.58 | 89 |
GSM687728 | Patient 452 control | 737.741 | 70 |
GSM687646 | Patient 401 treated 24h | 743.61 | 69 |
GSM687649 | Patient 402 treated 24h | 539.433 | 65 |
GSM687665 | Patient 411 treated 24h | 1764.94 | 82 |
GSM687651 | Patient 402 treated 4 weeks | 1784.52 | 82 |
GSM687667 | Patient 411 treated 4 weeks | 1668.48 | 81 |
GSM687670 | Patient 422 treated 24h | 2104.5 | 84 |
GSM687671 | Patient 422 treated 4 weeks | 2249.27 | 85 |
GSM687654 | Patient 403 treated 24h | 1490.99 | 80 |
GSM687675 | Patient 424 treated 24h | 1439.92 | 79 |
GSM687685 | Patient 427 treated 24h | 1505.11 | 80 |
GSM687656 | Patient 403 treated 4 weeks | 1417.06 | 79 |
GSM687677 | Patient 424 treated 4 weeks | 4173.16 | 92 |
GSM687687 | Patient 427 treated 4 weeks | 1636.47 | 81 |
GSM687692 | Patient 428 treated 4h | 1698.44 | 82 |
GSM687716 | Patient 449 treated 4h | 1381.62 | 79 |
GSM687722 | Patient 450 treated 4h | 1754.51 | 82 |
GSM687680 | Patient 425 treated 24h | 769.266 | 70 |
GSM687690 | Patient 428 treated 24h | 886.423 | 73 |
GSM687700 | Patient 443 treated 24h | 1589.19 | 81 |
GSM687705 | Patient 444 treated 24h | 2866.27 | 88 |
GSM687714 | Patient 449 treated 24h | 978.986 | 74 |
GSM687721 | Patient 450 treated 24h | 1415.5 | 79 |
GSM687682 | Patient 425 treated 4 weeks | 844.117 | 72 |
GSM687694 | Patient 428 treated 4 weeks | 1921.42 | 83 |
GSM687702 | Patient 443 treated 4 weeks | 1905.75 | 83 |
GSM687718 | Patient 449 treated 4 weeks | 1409.87 | 79 |
GSM687723 | Patient 450 treated 4 weeks | 1572.98 | 81 |
GSM687661 | Patient 404 treated 4h | 1299.38 | 78 |
GSM687710 | Patient 448 treated 4h | 1992.78 | 84 |
GSM687726 | Patient 451 treated 4h | 2784.55 | 88 |
GSM687730 | Patient 452 treated 4h | 1836.17 | 84 |
GSM687660 | Patient 404 treated 24h | 571.509 | 67 |
GSM687697 | Patient 441 treated 24h | 797.615 | 71 |
GSM687709 | Patient 448 treated 24h | 1573.8 | 81 |
GSM687725 | Patient 451 treated 24h | 3717.49 | 91 |
GSM687729 | Patient 452 treated 24h | 836.25 | 73 |
GSM687727 | Patient 451 treated 4 weeks | 5924.46 | 95 |
GSM687731 | Patient 452 treated 4 weeks | 1083.99 | 75 |